Skip to contentMOTT DAVID M — TESARO, Inc. insider: 528 transactions · InsiderLensMOTT DAVID M
- Director at MEDIMMUNE INC /DE · on record since Feb 27, 2006
- 10% owner at Clovis Oncology, Inc. · on record since Nov 22, 2011
- 10% owner at Ra Pharmaceuticals, Inc. · on record since Oct 31, 2016
- 10% owner at METAL MANAGEMENT INC · on record since Mar 28, 2012
- Director at TESARO, Inc. · on record since Jun 27, 2012
- 10% owner at TESARO, Inc. · on record since Jun 27, 2012
- 10% owner at Workday, Inc. · on record since Oct 18, 2012
- Director at Epizyme, Inc. · on record since May 30, 2013
- 10% owner at Epizyme, Inc. · on record since May 30, 2013
- 10% owner at INTERLEUKIN GENETICS INC · on record since May 23, 2013
- Director at Omthera Pharmaceuticals, Inc. · on record since Apr 17, 2013
- 10% owner at Omthera Pharmaceuticals, Inc. · on record since Apr 17, 2013
- 10% owner at TCW CONVERTIBLE SECURITIES FUND INC · on record since Aug 14, 2013
- 10% owner at Care.com Inc · on record since Jan 29, 2014
- 10% owner at HIVE Digital Technologies Ltd. · on record since Mar 27, 2014
- 10% owner at GLYCOMIMETICS INC · on record since Jan 15, 2014
- Director at ARDELYX, INC. · on record since Jun 18, 2014
- 10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
- 10% owner at Roka BioScience, Inc. · on record since Jul 22, 2014
- 10% owner at Journey Medical Corp · on record since Oct 8, 2014
- 10% owner at Tracon Pharmaceuticals, Inc. · on record since Jan 29, 2015
- 10% owner at SeaCube Container Leasing Ltd. · on record since Jan 29, 2015
- 10% owner at CHAMPIONS SPORTS INC · on record since Mar 24, 2015
- 10% owner at NUVELO INC · on record since Jun 17, 2015
- 10% owner at ARDELYX, INC. · on record since Jun 12, 2015
- 10% owner at Mirna Therapeutics, Inc. · on record since Sep 30, 2015
- 10% owner at ADVANCE TECHNOLOGIES INC · on record since Oct 20, 2015
- Director at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
- 10% owner at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
- 10% owner at AVEO PHARMACEUTICALS INC · on record since May 17, 2016
- 10% owner at Achaogen Inc · on record since Jun 7, 2016
- 10% owner at MULESOFT, INC · on record since Mar 22, 2017
- 10% owner at CASCADE CORP · on record since Feb 1, 2017
- 10% owner at APPIAN CORP · on record since May 31, 2017
- Director at Mersana Therapeutics, Inc. · on record since Jun 27, 2017
- 10% owner at Mersana Therapeutics, Inc. · on record since Jun 27, 2017
- 10% owner at Regulus Therapeutics Inc. · on record since Jul 31, 2017
- 10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
- 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 10, 2017
- 10% owner at GENOCEA BIOSCIENCES, INC. · on record since Jan 23, 2018
- Vice Chairman, CEO & President at MEDIMMUNE INC /DE · on record since Feb 18, 2005
- 10% owner at Strongbridge Biopharma plc · on record since Jan 9, 2018
- 10% owner at Surface Oncology, Inc. · on record since Apr 23, 2018
- 10% owner at PhaseBio Pharmaceuticals Inc · on record since Oct 24, 2018
- 10% owner at TAPIMMUNE INC · on record since Oct 18, 2018
- 10% owner at Tempest Therapeutics, Inc. · on record since Dec 11, 2018
- 10% owner at Elastic N.V. · on record since Oct 10, 2018
- Director at KNIGHT CAPITAL GROUP, INC. · on record since Jan 29, 2019
- 10% owner at KNIGHT CAPITAL GROUP, INC. · on record since Jan 29, 2019
- 10% owner at Trevi Therapeutics, Inc. · on record since May 13, 2019
- 10% owner at Mirum Pharmaceuticals, Inc. · on record since Jul 24, 2019
- 10% owner at Cloudflare, Inc. · on record since Sep 18, 2019
- 10% owner at Oyster Point Pharma, Inc. · on record since Oct 30, 2019
- 10% owner at ST PAUL TRAVELERS COMPANIES INC · on record since Dec 18, 2019
- 10% owner at Galera Therapeutics, Inc. · on record since Nov 12, 2019
- 10% owner at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
- Director at 11 GOOD ENERGY INC · on record since Mar 16, 2020
- 10% owner at Casper Sleep Inc. · on record since Feb 6, 2020
- Director at NOVAVAX INC · on record since Jun 26, 2020
Insider trading activity of MOTT DAVID M
- Transactions on record
- 528
- since Sep 16, 2003
- Open-market buys
- 121
- $401.2M
- Open-market sells
- 16
- $141.5M
- Companies traded
- 39
- last filing Jun 23, 2026
Figures computed from official regulatory filings — methodology.
Companies where MOTT DAVID M has traded
- NOVAVAX INC29 tx · $6.7M · Jun 23, 2026
- ARDELYX, INC.54 tx · $71.1M · Jun 18, 2026
- Mersana Therapeutics, Inc.50 tx · $33M · Jan 6, 2026
- Adaptimmune Therapeutics PLC18 tx · $54.1M · Jul 1, 2024
- Epizyme, Inc.54 tx · $33.4M · Aug 16, 2022
- 11 GOOD ENERGY INC12 tx · $313.6K · Jun 3, 2022
- Regulus Therapeutics Inc.5 tx · $11.7M · Dec 26, 2019
- Galera Therapeutics, Inc.7 tx · $5M · Nov 12, 2019
- Mirum Pharmaceuticals, Inc.3 tx · $6.8M · Jul 24, 2019
Track record of MOTT DAVID M
Statistical track record
Free- Open-market buys
- 134
- Last buy
- Feb 20, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of MOTT DAVID M
Co-insiders of MOTT DAVID M
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
3 tx · $15M · Jun 25, 2019
Makhzoumi MohamadACTELIS NETWORKS INC +8
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 23, 2026 | AwardD | 21,270 | 0.00 USD | — | SEC |
| Jun 23, 2026 | Exercise | 18,880 | — | — | SEC |
| Jun 23, 2026 | AwardD | 14,180 | 0.00 USD | — | SEC |
| Jun 23, 2026 | ExerciseD | -18,880 | 0.00 USD | — | SEC |
| Jun 18, 2026 | AwardD | 39,715 | 0.00 USD | — | SEC |
| Jun 18, 2026 | Award | 26,455 | 0.00 USD | — | SEC |
| Jun 18, 2026 | Award | 20,282 | 0.00 USD | — | SEC |
| Feb 23, 2026 | Buy | 333,333 | 5.84 USD | $1.9M | SEC |
| Jan 6, 2026 | OtherD | -1,002 | — | — | SEC |
| Jan 6, 2026 | OtherD | -400 | — | — | SEC |
| Jan 6, 2026 | OtherD | -181 | — | — | SEC |
| Jan 6, 2026 | OtherD | -264 | — | — | SEC |
| Jan 6, 2026 | OtherD | -2,460 | — | — | SEC |
| Jan 6, 2026 | OtherD | -1,800 | — | — | SEC |
| Jan 6, 2026 | OtherD | -2,200 | — | — | SEC |
| Jan 6, 2026 | OtherD | -740 | — | — | SEC |
| Jan 6, 2026 | OtherD | -788 | — | — | SEC |
| Jan 6, 2026 | OtherD | -734 | — | — | SEC |
| Jan 6, 2026 | Other | -23,546 | — | — | SEC |
| Jan 6, 2026 | Other | -383 | — | — | SEC |
| Jan 6, 2026 | OtherD | -1,000 | — | — | SEC |
| Jan 6, 2026 | OtherD | -1,011 | — | — | SEC |
| Jan 6, 2026 | OtherD | -368 | — | — | SEC |
| Jun 24, 2025 | AwardD | 28,326 | 6.42 USD | $181.9K | SEC |
| Jun 24, 2025 | AwardD | 18,884 | 0.00 USD | $0 | SEC |